{
    "clinical_study": {
        "@rank": "38555", 
        "brief_summary": {
            "textblock": "Expanded access to Stiripentol for patients with Dravet Syndrome.  This is a treatment plan,\n      and therefore patients will be monitored according to clinical standard of care."
        }, 
        "brief_title": "Treatment Plan to Provide Expanded Access to Stiripentol for Patients With Dravet Syndrome", 
        "condition": "Dravet Syndrome", 
        "condition_browse": {
            "mesh_term": "Epilepsies, Myoclonic"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  6 months and older\n\n          -  Diagnosis of Dravet Syndrome with intractable seizures\n\n        Exclusion Criteria:\n\n          -  Hypersensitivity to the active substance or to any of the excipients\n\n          -  Past history of psychoses in the form of episodes of delirium\n\n          -  Impaired hepatic and/or renal function, defined as creatinine >2 and/or\n             transaminase >4xULN"
            }, 
            "gender": "Both", 
            "maximum_age": "N/A", 
            "minimum_age": "6 Months"
        }, 
        "firstreceived_date": "November 7, 2013", 
        "id_info": {
            "nct_id": "NCT01983722", 
            "org_study_id": "2013-5518"
        }, 
        "intervention": {
            "intervention_name": "Stiripentol", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Stiripentol"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "November 7, 2013", 
        "location": {
            "contact": {
                "last_name": "David N Franz, MD", 
                "phone": "513-636-4222"
            }, 
            "facility": {
                "address": {
                    "city": "Cincinnati", 
                    "country": "United States", 
                    "state": "Ohio", 
                    "zip": "45229"
                }, 
                "name": "Cincinnati Children's Hospital Medical Center"
            }, 
            "investigator": {
                "last_name": "David N Franz, MD", 
                "role": "Principal Investigator"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Treatment Plan to Provide Expanded Access to Stiripentol for Patients With Dravet Syndrome", 
        "overall_contact": {
            "last_name": "David N Franz, MD", 
            "phone": "513-636-4222"
        }, 
        "overall_status": "Available", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "N/A", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01983722"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Children's Hospital Medical Center, Cincinnati", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Children's Hospital Medical Center, Cincinnati", 
                "agency_class": "Other"
            }
        }, 
        "study_design": "N/A", 
        "study_type": "Expanded Access", 
        "verification_date": "November 2013"
    }
}